drugset
drugset / Trial / NCT00955058

Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients

NCT00955058 ↗

Phase 2/3 Unknown 60 enrolled Shahid Beheshti University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compound.

Timeline

Start
2007-02
Primary completion
2007-02
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject cyproterone acetate Small molecule — Oral
Subject ethinyl estradiol Small molecule — Oral

Indications

polycystic ovary syndrome